Reduction of chronic hepatitis B‐related hepatocellular carcinoma with anti‐viral therapy, including low risk patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|44|8|846-855

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.44, Iss.8, 2016-10, pp. : 846-855

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Letter: pre‐ and post‐operative anti‐viral therapy is important for patients with hepatitis B virus‐related hepatocellular carcinoma

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 8, 2015-04 ,pp. : 789-790

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: pre‐ and post‐operative anti‐viral therapy is important for patients with hepatitis B virus‐related hepatocellular carcinoma – authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 8, 2015-04 ,pp. : 790-790

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatocellular carcinoma risk in chronic hepatitis B virus–infected compensated cirrhosis patients with low viral load

By  

HEPATOLOGY, Vol. 62, Iss. 3, 2015-09 ,pp. : 694-701

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antiviral therapy in the improvement of survival of patients with hepatitis B virus‐related hepatocellular carcinoma treated with sorafenib

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 6, 2015-06 ,pp. : 1032-1039

John Wiley & Sons Inc

Access to resources Recommend Favorite

Postoperative hepatitis B virus reactivation and surgery‐induced immunosuppression in patients with hepatitis B‐related hepatocellular carcinoma

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 6, 2015-11 ,pp. : 634-642

John Wiley & Sons Inc

Access to resources Recommend Favorite